How to Help Your Patients Find Iyuzeh in Stock: A Provider's Guide

You've prescribed Iyuzeh (preservative-free Latanoprost 0.005%) for a patient with open-angle glaucoma or ocular hypertension — and now they're calling your office because they can't find it. Sound familiar?

Iyuzeh fills an important clinical role as the only preservative-free Latanoprost on the U.S. market. But its newness, brand-only status, and limited retail pharmacy stocking mean that providers need to take an active role in ensuring patient access. This guide outlines practical steps to help your patients find and afford Iyuzeh in 2026.

Current Availability Landscape

Iyuzeh is not in shortage. Thea Pharma continues to manufacture and distribute the product through standard pharmaceutical channels. The access problem is at the last mile — retail pharmacy stocking:

• Large chain pharmacies (CVS, Walgreens, Rite Aid) frequently don't stock Iyuzeh due to low volume
• Independent pharmacies are more flexible and can typically order Iyuzeh within 1–2 business days
• PhilRx home delivery (Thea Pharma's partner pharmacy) is the most consistent access point

The cash price ranges from $264–$350 per month, compared to $10–$30 for generic preserved Latanoprost. This price differential drives most of the insurance and pharmacy stocking challenges.

Why Patients Can't Find Iyuzeh

Understanding the barriers helps you address them proactively:

1. Pharmacy doesn't stock it: Most retail pharmacies only stock medications with consistent demand. Iyuzeh is too new and too niche for many locations.
2. Insurance requires prior authorization: Many payers mandate step therapy through generic Latanoprost before approving Iyuzeh, creating a delay.
3. Patient doesn't know about alternatives to retail: Many patients don't realize they can get Iyuzeh through home delivery or from independent pharmacies.
4. Cost shock: Patients who see the $264+ cash price at the register may abandon the prescription, not knowing about savings programs.

What Providers Can Do: 5 Steps

Step 1: Set Expectations at the Point of Prescribing

When you prescribe Iyuzeh, tell the patient upfront:

• "This is a newer brand-name medication that some pharmacies don't carry yet."
• "There are savings programs that can bring the cost way down."
• "I'm going to help make sure you can get it filled."

This prevents the frustration and phone calls that come when patients are blindsided at the pharmacy.

Step 2: Route the Prescription to PhilRx

Thea Pharma's PhilRx program is the most reliable way to get Iyuzeh to patients. Benefits include:

• Free home delivery
• PA submission support (PhilRx handles the paperwork)
• Insurance verification and benefits investigation
• Automatic refill reminders
• Copay as low as $60/month for commercially insured patients, or $120 for a 90-day supply

Send the prescription electronically to PhilRx, and patients will receive a text from 744-579 to complete enrollment. No paper forms required.

Step 3: Use Medfinder to Identify Stocking Pharmacies

Medfinder for Providers lets you check which pharmacies near your patient's location currently have Iyuzeh in stock. Use it to:

• Direct patients to a specific pharmacy that has the drug
• Identify independent pharmacies in your area that regularly stock Iyuzeh
• Build a short list of "go-to" pharmacies for Iyuzeh prescriptions

Consider bookmarking medfinder.com/providers on your office computers and sharing it with your front desk and technician staff.

Step 4: Prepare Prior Authorization Materials

For patients whose insurance requires PA, having templates ready saves time:

• Document ocular surface disease, BAK sensitivity, or chronic conjunctival inflammation
• Note any prior adverse reactions to preserved Latanoprost or other BAK-containing drops
• Reference the clinical rationale for preservative-free therapy (e.g., planned surgery, multi-drop regimen, dry eye comorbidity)
• Include the Phase 3 trial data showing clinical equivalence to Xalatan

PhilRx can submit PA on your behalf if the prescription is routed through their system, reducing the administrative burden on your staff.

Step 5: Provide Savings Information to Patients

Before the patient leaves your office, give them information about savings programs:

• Copay Card: As low as $60/month at local pharmacies (commercially insured patients)
• Cash Program: $75/fill for patients paying out of pocket
• PhilRx Home Delivery: As low as $120 for 90-day supply with free shipping
• Website: myiyuzehsavings.com

Having printed cards or a QR code in exam rooms can streamline this step. None of these programs are available to patients on Medicare, Medicaid, or other government insurance.

Alternatives When Iyuzeh Isn't Accessible

When Iyuzeh can't be obtained or covered, consider these options based on the clinical situation:

• Travatan Z (Travoprost 0.004%): BAK-free (SofZia preserved). Best alternative for preservative-sensitive patients. More widely stocked and easier to get covered.
• Generic Latanoprost: Same active ingredient, $10–$30/month. Appropriate when the patient can tolerate BAK.
• Generic Bimatoprost: Effective PGA, $15–$50/month. Contains BAK.
• Vyzulta (Latanoprostene Bunod): Dual-mechanism option for patients needing additional IOP lowering. Brand only, $200–$350/month.

For patient-facing details, direct patients to our alternatives guide.

Workflow Tips for Your Practice

Here are some practical workflow improvements to reduce Iyuzeh access friction:

• Create an Iyuzeh protocol: Document your standard process for prescribing Iyuzeh, including PhilRx routing, PA templates, and savings card distribution.
• Train front desk staff: Equip them to answer the most common patient questions about Iyuzeh availability and direct patients to Medfinder or PhilRx.
• Keep samples on hand: Bridge samples ensure patients don't miss doses while waiting for PA approval or delivery.
• Bookmark Medfinder: Use it as part of your prescribing workflow to verify availability before the patient leaves.
• Follow up: Have a staff member check in with patients 48–72 hours after prescribing to confirm they were able to fill the prescription.

Final Thoughts

Iyuzeh is a clinically valuable option for patients who need preservative-free IOP-lowering therapy. The access challenges are real but manageable with proactive prescribing practices. By routing prescriptions through PhilRx, using Medfinder for Providers to identify stocking pharmacies, providing savings information upfront, and keeping PA materials ready, you can significantly improve the likelihood that your patients get this medication without delays or frustration.

For the latest availability updates, see our Iyuzeh shortage briefing for providers. For cost-saving strategies to share with patients, see our provider's guide to helping patients save on Iyuzeh.